BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19407554)

  • 1. Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells.
    Yi Z; Jingting C; Yu Z
    Int J Gynecol Cancer; 2009 Apr; 19(3):326-33. PubMed ID: 19407554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H; Ye Y; Bai Z; Wang S
    Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
    Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
    Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest.
    Baek JY; Hur W; Wang JS; Bae SH; Yoon SK
    World J Gastroenterol; 2007 Feb; 13(8):1175-81. PubMed ID: 17451196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism and effect of selective cyclooxygenase-2 inhibitor NS-398 on human cervical carcinoma cells].
    Li XG; Wu M; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):877-82. PubMed ID: 18007088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2.
    Liu JF; Zhu GJ; Jamieson GG; Wu TC; Zhu TN; Shan BE; Drew PA
    Cancer Invest; 2009 Jan; 27(1):17-23. PubMed ID: 19160097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
    Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
    Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
    Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
    Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of gastrin receptor antagonist and cyclooxygenase-2 inhibitor on proliferation and apoptosis of gastric cancer cell].
    Sun WH; Su H; Zhang LJ; Shao Y; Xu HC; Zhang T; Xue YP; Ding GX; Cheng YL
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):250-4. PubMed ID: 16677505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
    Ma AY; Xie SW; Zhou JY; Zhu Y
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
    Leung E; McArthur D; Morris A; Williams N
    Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells.
    Lee LR; Teng PN; Nguyen H; Hood BL; Kavandi L; Wang G; Turbov JM; Thaete LG; Hamilton CA; Maxwell GL; Rodriguez GC; Conrads TP; Syed V
    Cancer Prev Res (Phila); 2013 Jul; 6(7):731-43. PubMed ID: 23682076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line.
    Yamashita H; Osaki M; Honjo S; Yoshida H; Teshima R; Ito H
    Anticancer Res; 2003; 23(6C):4671-6. PubMed ID: 14981912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor].
    Song IH; Kim DW; Shin KC; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Kim EY
    Korean J Hepatol; 2008 Sep; 14(3):351-9. PubMed ID: 18815458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.